{
  "id": 12640454,
  "title": "Ukrainian drugmakers sold $114 million worth of medicines to Uzbekistan in six months. Now they may lose the right to sell there",
  "url": "https://urgent.news/2026/10/07/ukrainian-drugmakers-sold-114-million-worth-of-medicines-to",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-07T14:01:10.000Z",
  "source": {
    "name": "Euromaidan Press",
    "slug": "euromaidan-press",
    "url": "https://euromaidanpress.com/2026/10/07/ukrainian-drugmakers-sold-114-million-worth-of-medicines-to-uzbekistan-in-six-months-now-they-may-lose-the-right-to-sell-there/"
  },
  "original_language": "en",
  "account": "Ukrainian pharmaceutical firms generated $114 million in sales to Uzbekistan over the first half of 2026, marking a significant increase from 2021. However, these sales could potentially be jeopardized as Uzbekistan plans to discontinue remote factory inspections next year. Inspectors are currently hesitant to travel to war-torn Ukraine. The country grants three-year General Manufacturing Practice certificates after inspecting facilities, a process that is set to end on January 1, 2027.\n\nAround 30% of Ukraine's foreign-currency earnings come from this market, making it the top foreign market for four of the industry's five biggest drugmakers by revenue. Losing Uzbekistan as a customer could force these companies to hike domestic prices or discontinue low-margin medicines, adversely impacting patients. Farmak, the largest of these firms, generates 35% of its exports for Uzbekistan. However, wartime currency rules limit payment terms to 180 days, whereas foreign buyers frequently require longer payment periods. As a result, some of Farmak's trade is routed through its Polish subsidiary.\n\nThe Uzbek government has drafted rules for remote inspections under extraordinary circumstances, but no concrete action has been taken yet. Ukrainian companies have sought assistance from the Presidential Office, Foreign Ministry, and Health Ministry, but no Ukrainian experts have been dispatched to Uzbekistan as of yet. While Russia currently holds nearly the same market share as Ukraine in Uzbekistan, it remains poised to assume Ukraine's position if necessary.",
  "summary": "That export cash keeps medicine prices low at home. Without it, drugs could get pricier for Ukrainian patients, a former regulator official says.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}